289 related articles for article (PubMed ID: 21080969)
1. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
Han JS; Crowe DL
BMC Cancer; 2010 Nov; 10():629. PubMed ID: 21080969
[TBL] [Abstract][Full Text] [Related]
2. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
Buroker NE; Barboza J; Huang JY
FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
[TBL] [Abstract][Full Text] [Related]
3. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
4. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
[TBL] [Abstract][Full Text] [Related]
6. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
8. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
Ku TK; Crowe DL
J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1.
Chaudhry AZ; Vitullo AD; Gronostajski RM
J Biol Chem; 1999 Mar; 274(11):7072-81. PubMed ID: 10066764
[TBL] [Abstract][Full Text] [Related]
10. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.
Qin L; Liu Z; Chen H; Xu J
Cancer Res; 2009 May; 69(9):3819-27. PubMed ID: 19383905
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.
Karim SA; Creedon H; Patel H; Carragher NO; Morton JP; Muller WJ; Evans TR; Gusterson B; Sansom OJ; Brunton VG
J Pathol; 2013 Aug; 230(4):430-40. PubMed ID: 23616343
[TBL] [Abstract][Full Text] [Related]
12. Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Brown PH; Subbaramaiah K; Salmon AP; Baker R; Newman RA; Yang P; Zhou XK; Bissonnette RP; Dannenberg AJ; Howe LR
Cancer Prev Res (Phila); 2008 Aug; 1(3):208-14. PubMed ID: 19138958
[TBL] [Abstract][Full Text] [Related]
13. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
[TBL] [Abstract][Full Text] [Related]
14. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
[TBL] [Abstract][Full Text] [Related]
15. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Qi C; Zhu Y; Reddy JK
Cell Biochem Biophys; 2000; 32 Spring():187-204. PubMed ID: 11330046
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
Lu Y; Bertran S; Samuels TA; Mira-y-Lopez R; Farias EF
Oncogene; 2010 Jun; 29(25):3665-76. PubMed ID: 20453882
[TBL] [Abstract][Full Text] [Related]
20. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
Yee LD; Young DC; Rosol TJ; Vanbuskirk AM; Clinton SK
J Nutr; 2005 May; 135(5):983-8. PubMed ID: 15867269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]